Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG)

Nuclear Medicine Communications

Volumn 22, Issue 7, 2001, Pages 747-753

  Lederman, R J ^a   Raylman, R R ^a   Fisher, S J ^a   Kison, P V ^a   San, H ^a   Nabel, E G ^a   Wahl, R L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Atherosclerosis; Fludeoxyglucose F18; Inflammation; Positron; Radionuclide imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; ILIAC ARTERY; INFLAMMATION; INJECTION; INTIMA; MACROPHAGE; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; POSITRON; SCINTISCANNING;

ANIMALS; ARTERIES; ARTERIOSCLEROSIS; AUTORADIOGRAPHY; FLUORODEOXYGLUCOSE F18; IMMUNOHISTOCHEMISTRY; MALE; RABBITS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034952536     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200107000-00004     Document Type: Review

References (22)

1. Little WC, Constantinescu M, Applegate RJ et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78: 1157-1166.
2. Ambrose JA, Tannenbaum MA, Alexopoulos D et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62.
3. Singh RN. Progression of coronary atherosclerosis. Clues to pathogenesis from serial coronary arteriography. Br Heart J 1984; 52: 451-461.
4. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997; 350: 461-468.
5. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
6. Raylman RR, Wahl RL. A fiber-optically coupled positron-sensitive surgical probe. J Nucl Med 1994; 35: 909-913.
7. Raylman RR, Fisher SJ, Brown RS, Ethier SP, Wahl RL. Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies. J Nucl Med 1995; 36: 1869-1874.
8. Simari RD, San H, Rekhter M et al. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest 1996; 98: 225-235.
9. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
10. MacIsaac AI, Thomas JD, Topol EJ. Toward the quiescent coronary plaque. J Am Coll Cardiol 1993; 22: 1228-1241.
11. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671.
12. Davies MJ. Detecting vulnerable coronary plaques. Lancet 1996; 347: 1422-1423.
13. Vallabhajosula S, Machac J, Knesaurek K et al. Imaging atherosclerotic lesions by positron emission tomography (PET) using F-18-fluorodeoxyglucose (FDG): preclinical studies in hypercholesterolemic rabbits [Abstract]. Circulation 1995; 92: 313.
14. Helft G, Worthley S, Zhang Z et al. Non-invasive in vivo imaging of atherosclerotic lesions with fluorine-18 deoxyglucose (18-FDG) PET correlates with macrophage content in a rabbit model [Abstract]. Circulation 1999; 18: I-311.
15. Casscells W, Hathorn B, David M et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 1996; 347: 1447-1451.
16. Stefanadis C, Diamantopoulos L, Vlachopoulos C et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation 1999; 99: 1965-1971.
17. Romer TJ, Brennan JF, 3rd, Fitzmaurice M et al. Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy. Circulation 1998; 97: 878-885.
18. Fujimoto JG, Boppart SA, Tearney GJ, Bouma BE, Pitris C, Brezinski ME. High resolution in vivo intra-arterial imaging with optical coherence tomography. Heart 1999; 82: 128-133.
19. Brezinski ME, Tearney GJ, Weissman NJ et al. Assessing atherosclerotic plaque morphology: comparison of optical coherence tomography and high frequency intravascular ultrasound. Heart 1997; 77: 397-403.
20. Fayad Z, Fallon J, Shinnar M et al. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation 1998; 98: 1541-1547.
21. Zimmermann-Paul GG, Quick HH, Vogt P, von Schulthess GK, Kling D, Debatin JF. High-resolution intravascular magnetic resonance imaging: monitoring of plaque formation in heritable hyperlipidemic rabbits. Circulation 1999; 99: 1054-1061.
22. Guo B, Willerson J, Bearman G et al. Infrared fiber optic thermal imaging of atherosclerotic plaques [Abstract]. Circulation 1999; 18: I-446.